• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

GE Healthcare Teams up with Augmented Reality Company MediView XR

Share:

December 5, 2022

GE Healthcare and MediView XR, a med-tech company that leverages augmented reality, announced their collaboration to co-develop the OmnifyXR Interventional Suite System. It will combine medical imaging and mixed-reality solutions to assist physicians and their care teams.

The collaboration will pair GE’s imaging technologies with MediView’s augmented reality and surgical navigation expertise to allow physicians to evaluate multiple holographic displays of live imaging in 3D using Microsoft’s HoloLens technology.

The aim is to help physicians better assess a patient’s anatomy, make more informed clinical decisions and allow for remote collaboration by care teams in different locations.

OmnifyXR will be designed and manufactured by MediView XR, and will initially launch in the U.S.

“We are thrilled to advance our strategic collaboration with GE Healthcare by co-developing and creating the interventional suite of the future –- one that is designed to improve ergonomics, with natural interactions for optimized workflow and facilitates care team collaboration.

“The physician is empowered to simultaneously interface with virtual monitors, holographic 3D anatomy and remotely collaborate with colleagues around the world,” Mina Fahim, president and CEO of MediView, said in a statement.

THE LARGER TREND

In 2021 GE announced its plans to spin off its healthcare unit in early 2023 to separate the company into three public companies, of which one was GE Healthcare.

In October the company released details about its progress in splitting the company, noting its plans to organize GE Healthcare into four segments: imaging, patient care solutions (which will include monitoring and digital tools), pharmaceutical diagnostics and ultrasound.

GE Healthcare acquired surgical visualization company BK Medical for $1.45 billion in 2021. Previously it purchased both Zionexa, a developer of in-vivo biomarkers to guide cancer treatment, and Swedish medical x-ray-imaging startup Prismatic Sensors.

In October, the healthcare giant announced its partnership with AMC Health to offer remote patient monitoring technology to patients after they’ve been discharged from the hospital.

Source: Mobi Health News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • KLAS: COVID-19 Guide to Telehealth Virtual Care & Remote Care PlatformsKLAS: COVID-19 Guide to Telehealth Virtual Care & Remote Care Platforms
  • VerityStream Acquires CredentialMyDoc for $9M in CashVerityStream Acquires CredentialMyDoc for $9M in Cash
  • Masimo to Acquire Connected Care Business from NantHealthMasimo to Acquire Connected Care Business from NantHealth
  • CF Pharmtech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory DrugsCF Pharmtech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
  • Schweiger Dermatology Group Announces Acquisition of Dermatology & Skin Surgery Center, with Locations in Chester County, PennsylvaniaSchweiger Dermatology Group Announces Acquisition of Dermatology & Skin Surgery Center, with Locations in Chester County, Pennsylvania
  • Uptiv & Lyn Unite: Transforming Chronic Care Together!Uptiv & Lyn Unite: Transforming Chronic Care Together!
  • Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.
  • Varian takes out CyberHeartVarian takes out CyberHeart

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications